Home
Scholarly Works
142 Phase II study of imatinib mesylate in...
Conference

142 Phase II study of imatinib mesylate in salivary gland adenoid cystic carcinoma

Authors

Winquist E; Lamont E; Hotte S; MacKenzie M; Brown S; Murgo A; Siu L

Volume

1

Pagination

pp. s46-s47

Publisher

Elsevier

Publication Date

September 1, 2003

DOI

10.1016/s1359-6349(03)90175-3

Conference proceedings

European Journal of Cancer Supplements

Issue

5

ISSN

1359-6349

Contact the Experts team